S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
First-Time Investor? Here Are 9 Mistakes You Want To Avoid
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Ford Stock Going Forward After Big Earnings Flop
Are Penny Stocks Worth it? Should You Invest in Penny Stocks?
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Closing prices for crude oil, gold and other commodities
AI Software Maker EPAM Boasts Biggest Tech-Sector Rally
“Future Fuel” will unleash $11 trillion wave of wealth (Ad)
Indian tycoon Adani hit by more losses, calls for probe
Ford, Starbucks fall; Clorox, Gilead Sciences rise
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
First-Time Investor? Here Are 9 Mistakes You Want To Avoid
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Ford Stock Going Forward After Big Earnings Flop
Are Penny Stocks Worth it? Should You Invest in Penny Stocks?
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Closing prices for crude oil, gold and other commodities
AI Software Maker EPAM Boasts Biggest Tech-Sector Rally
“Future Fuel” will unleash $11 trillion wave of wealth (Ad)
Indian tycoon Adani hit by more losses, calls for probe
Ford, Starbucks fall; Clorox, Gilead Sciences rise
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
First-Time Investor? Here Are 9 Mistakes You Want To Avoid
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Ford Stock Going Forward After Big Earnings Flop
Are Penny Stocks Worth it? Should You Invest in Penny Stocks?
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Closing prices for crude oil, gold and other commodities
AI Software Maker EPAM Boasts Biggest Tech-Sector Rally
“Future Fuel” will unleash $11 trillion wave of wealth (Ad)
Indian tycoon Adani hit by more losses, calls for probe
Ford, Starbucks fall; Clorox, Gilead Sciences rise
S&P 500   3,852.36
DOW   32,920.46
QQQ   306.18
First-Time Investor? Here Are 9 Mistakes You Want To Avoid
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Ford Stock Going Forward After Big Earnings Flop
Are Penny Stocks Worth it? Should You Invest in Penny Stocks?
Know Your Profit Potential BEFORE You Trade! (Ad)pixel
Closing prices for crude oil, gold and other commodities
AI Software Maker EPAM Boasts Biggest Tech-Sector Rally
“Future Fuel” will unleash $11 trillion wave of wealth (Ad)
Indian tycoon Adani hit by more losses, calls for probe
Ford, Starbucks fall; Clorox, Gilead Sciences rise

Global Medical REIT - GMRE Stock Forecast, Price & News

$11.30
-0.22 (-1.91%)
(As of 02/3/2023 12:00 AM ET)
Add
Compare
Today's Range
$11.25
$11.43
50-Day Range
$9.25
$11.52
52-Week Range
$7.01
$16.52
Volume
511,060 shs
Average Volume
403,734 shs
Market Capitalization
$740.38 million
P/E Ratio
45.20
Dividend Yield
7.29%
Price Target
$16.50

Global Medical REIT MarketRank™ Forecast

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
46.0% Upside
$16.50 Price Target
Short Interest
Healthy
2.37% of Shares Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
-3.19
Upright™ Environmental Score
News Sentiment
1.51mentions of Global Medical REIT in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
2.17%
From $0.92 to $0.94 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.77 out of 5 stars

Finance Sector

109th out of 865 stocks

Real Estate Investment Trusts Industry

17th out of 189 stocks

GMRE stock logo

About Global Medical REIT (NYSE:GMRE) Stock

Global Medical REIT, Inc. engages in the acquisition of purpose-built healthcare facilities and leasing of those properties to strong healthcare systems and physician groups. The company was founded on March 18, 2011 and is headquartered in Bethesda, MD.

Receive GMRE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Global Medical REIT and its competitors with MarketBeat's FREE daily newsletter.

GMRE Stock News Headlines

GMRE Global Medical REIT Inc.
“Future Fuel” will unleash $11 trillion wave of wealth
The next major energy revolution is unfolding right now. And it could hand early investors as much as 46,700% gains…
Global Medical REIT Stock (NYSE:GMRE), Dividends
Global Medical REIT Inc (3UN.MU)
Global Medical REIT Inc. (GMRE-PA)
A gold storm is coming…
“We are in the early stages of a mania – the calm before the storm.”...
3 REIT Stocking Stuffers Yielding 8%
3 Fast-Growing Medical REITs At Attractive Prices
JMP Securities Reaffirms Their Hold Rating on Global Medical REIT (GMRE)
Global Medical REIT (GMRE) Q3 FFO Lag Estimates
GMRE.PA Global Medical REIT Inc. 7.50% CUM PFD A
Global Medical REIT Now Has A 9% Recession Resistant Yield
Flying Under The Radar: 3 Small-Cap Healthcare REIT Gems
Short Volatility Alert: Global Medical REIT Inc.
See More Headlines
Receive GMRE Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Global Medical REIT and its competitors with MarketBeat's FREE daily newsletter.

GMRE Company Calendar

Last Earnings
5/04/2022
Ex-Dividend for 1/9 Dividend
12/21/2022
Dividend Payable
1/09/2023
Today
2/04/2023
Next Earnings (Estimated)
2/27/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Real estate investment trusts
Sub-Industry
N/A
Sector
Finance
Fax
N/A
Employees
26
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$16.50
High Stock Price Forecast
$17.00
Low Stock Price Forecast
$16.00
Forecasted Upside/Downside
+46.0%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
3 Analysts

Profitability

Net Income
$17.62 million
Pretax Margin
18.00%

Debt

Sales & Book Value

Annual Sales
$115.94 million
Cash Flow
$1.02 per share
Book Value
$8.76 per share

Miscellaneous

Free Float
60,539,000
Market Cap
$740.38 million
Optionable
Optionable
Beta
1.08

Key Executives

  • Jeffrey Mark BuschJeffrey Mark Busch
    Chairman, President & Chief Executive Officer
  • Danica Holley
    Chief Operating Officer
  • Robert J. Kiernan
    Chief Financial Officer & Treasurer
  • Alfonzo Leon
    Chief Investment Officer
  • Allen E. Webb
    Senior VP-SEC Reporting & Technical Accounting













GMRE Stock - Frequently Asked Questions

Should I buy or sell Global Medical REIT stock right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Global Medical REIT in the last year. There are currently 3 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" GMRE shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in GMRE, but not buy additional shares or sell existing shares.
View GMRE analyst ratings
or view top-rated stocks.

What is Global Medical REIT's stock price forecast for 2023?

3 Wall Street analysts have issued 12-month price targets for Global Medical REIT's shares. Their GMRE share price forecasts range from $16.00 to $17.00. On average, they predict the company's share price to reach $16.50 in the next year. This suggests a possible upside of 46.0% from the stock's current price.
View analysts price targets for GMRE
or view top-rated stocks among Wall Street analysts.

How have GMRE shares performed in 2023?

Global Medical REIT's stock was trading at $9.48 at the beginning of the year. Since then, GMRE stock has increased by 19.2% and is now trading at $11.30.
View the best growth stocks for 2023 here
.

Are investors shorting Global Medical REIT?

Global Medical REIT saw a decline in short interest in the month of January. As of January 15th, there was short interest totaling 1,550,000 shares, a decline of 12.9% from the December 31st total of 1,780,000 shares. Based on an average daily volume of 604,700 shares, the short-interest ratio is currently 2.6 days.
View Global Medical REIT's Short Interest
.

When is Global Medical REIT's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, February 27th 2023.
View our GMRE earnings forecast
.

How were Global Medical REIT's earnings last quarter?

Global Medical REIT Inc. (NYSE:GMRE) released its quarterly earnings results on Wednesday, May, 4th. The company reported $0.04 earnings per share for the quarter, missing the consensus estimate of $0.23 by $0.19. Global Medical REIT had a trailing twelve-month return on equity of 3.76% and a net margin of 16.48%. During the same period in the prior year, the business posted $0.24 earnings per share.

How often does Global Medical REIT pay dividends? What is the dividend yield for Global Medical REIT?

Global Medical REIT declared a quarterly dividend on Wednesday, December 7th. Investors of record on Thursday, December 22nd will be paid a dividend of $0.21 per share on Monday, January 9th. This represents a $0.84 annualized dividend and a dividend yield of 7.43%. The ex-dividend date of this dividend is Wednesday, December 21st.
Read our dividend analysis for GMRE
.

Is Global Medical REIT a good dividend stock?

Global Medical REIT (NYSE:GMRE) pays an annual dividend of $0.84 per share and currently has a dividend yield of 7.40%. GMRE has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The company has been increasing its dividend for 2 consecutive year(s), indicating that it does not yet have a strong track record of dividend growth. The dividend payout ratio is 336.00%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on EPS estimates, GMRE will have a dividend payout ratio of 89.36% in the coming year. This indicates that the company may not be able to sustain their current dividend.
Read our dividend analysis for GMRE.

What other stocks do shareholders of Global Medical REIT own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Global Medical REIT investors own include INSYS Therapeutics (INSY), General Electric (GE), New Residential Investment (NRZ), AT&T (T), Big Lots (BIG), Block (SQ), Energy Transfer (ET), Medical Properties Trust (MPW) and AGNC Investment (AGNC).

When did Global Medical REIT IPO?

(GMRE) raised $130 million in an initial public offering (IPO) on Wednesday, June 29th 2016. The company issued 13,000,000 shares at $10.00 per share. Wunderlich and Oppenheimer served as the underwriters for the IPO and BB&T Capital Markets, Compass Point and D.A. Davidson were co-managers.

What is Global Medical REIT's stock symbol?

Global Medical REIT trades on the New York Stock Exchange (NYSE) under the ticker symbol "GMRE."

Who are Global Medical REIT's major shareholders?

Global Medical REIT's stock is owned by many different institutional and retail investors. Top institutional investors include Phocas Financial Corp. (1.25%), State of New Jersey Common Pension Fund D (1.23%), Sound Income Strategies LLC (1.00%), Allspring Global Investments Holdings LLC (0.44%), D.A. Davidson & CO. (0.41%) and International Assets Investment Management LLC (0.30%). Insiders that own company stock include Henry Cole, Jeffrey Busch and Ronald Marston.
View institutional ownership trends
.

How do I buy shares of Global Medical REIT?

Shares of GMRE stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Global Medical REIT's stock price today?

One share of GMRE stock can currently be purchased for approximately $11.30.

How much money does Global Medical REIT make?

Global Medical REIT (NYSE:GMRE) has a market capitalization of $740.38 million and generates $115.94 million in revenue each year. The company earns $17.62 million in net income (profit) each year or $0.25 on an earnings per share basis.

How can I contact Global Medical REIT?

Global Medical REIT's mailing address is 2 Bethesda Metro Center Suite 440, BETHESDA MD, 20814. The official website for the company is www.globalmedicalreit.com. The company can be reached via phone at (202) 524-6851 or via email at investors@globalmedicalreit.com.

This page (NYSE:GMRE) was last updated on 2/4/2023 by MarketBeat.com Staff